Sublobar Resection for Early Peripheral Non-Small Cell Lung Cancer

The optimal surgical approach for early-stage peripheral non-small cell lung cancer is a topic of significant clinical debate. While lobectomy has long been the standard of care, recent evidence from two landmark clinical trials, JCOG0802/WJOG4607L and CALGB140503, is challenging traditional practices and refining the role of sublobar resection. Establishing clear indications for less invasive, lung-sparing procedures like segmentectomy and partial resection is essential for improving patient outcomes in thoracic surgery.The optimal surgical approach for early-stage peripheral non-small cell lung cancer is a topic of significant clinical debate. While lobectomy has long been the standard of care, recent evidence from two landmark clinical trials, JCOG0802/WJOG4607L and CALGB140503, is challenging traditional practices and refining the role of sublobar resection. Establishing clear indications for less invasive, lung-sparing procedures like segmentectomy and partial resection is essential for improving patient outcomes in thoracic surgery.

Clinical Background

1. Opening Message from JACS - Prof. Shinichi Toyooka (Japan)

2. Welcome & Introduction - Dr. Kenji Suzuki (Japan)

3. Matters of debate on Sublobar Resection for Lung Cancer - Dr. Kenji Suzuki (Japan)

4. CALGIB Study results and Indications for a Segmentectomy and Partial Resection - Dr. Nasser Khaled Altorki (USA)

5. Current Perspectives on Indications for Segmentectomy and Wedge Resection in Japan - Dr. Yasuhiro Tsutani (Japan)

6. Panel Discussion & Closing Remarks - All faculty moderated by Dr. Kenji Suzuki (Japan)